Thrombosis, embolism and infarction Flashcards
Thrombosis
A thrombus is defined as a solid mass formed in the living circulation from the components of the streaming blood. This serves to distinguish it from a clot which may form:
- outside the body
- in a dead body
- outside of the vasculature
Thrombosis (the formation of thrombus) is a well- ordered series of events involving the blood platelets and the clotting cascade. Platelets adhere to areas of endothelial damage and if the stimulus is strong enough will go on to platelet activation with shape change and release of a number of substances which enhance the process of thrombosis at the same time as aggregating together.
Stages in the development of thrombosis I
Thrombus may form in the heart, arteries, veins, or capillaries. The first stage involves platelets sticking to the damaged endothelium, and then a dense layer of fibrin and leucocytes adhere to the surface of the platelet. Blood clot (fibrin and red cells) develops on this layer of leucocytes and platelets, and then a secondary layer of platelets collects on the surface of the blood clot.
The gradual extension of thrombosis leads to a propagated or consecutive thrombus. Organization then begins with adherence to the wall of the vessel as mural thrombus. A second stage develops with a further batch of platelets laid down over the initial aggregate and then a further layer of blood clot. In this way alternate layers of platelets and blood clot form a laminar arrangement.
This causes a differential contraction
of platelets and fibrin and gives a rippled appearance reminiscent of rippling of the sand on a beach. This has also been described as having a coralline appearance.
The ridges on the surface of the thrombi are known as the lines of Zahn.
Causes of thrombosis
Several factors contribute to thrombus formation and these are usually grouped together under three headings (Virchows triad). The factors in Virchow’s triad are:
- damage to the vessel wall
- alterations in blood flow
- alterations in the constituents of the blood
Not all these factors need to be present at the same time; some will be dominant in one clinical situation whilst others will predominate in another. For example, venous thrombosis is commonly due to alterations in blood flow, while arterial thrombosis is more commonly due to vessel wall changes of atheroma, which does not occur in veins.
Virchows triad: Damage to the vessel wall
- Arteries – atherosclerotic plaques or synthetic grafts
- Heart – congenital abnormalities or artificial valves
- Veins – local injury caused by pressure on the calves from bed or operating table or by insertion of intravenous cannulae; or distortion of the femoral vein during hip replacement.
Virchows triad: Damage to the vessel wall: Arterial thrombosis
Atheroma of the arterial wall presents a good example of how vessel damage can lead to thrombosis and it is also a very common and important clinical situation.
Vascular endothelial cells have intrinsic fibrinolytic activity in which plasminogen, an inactive plasma protein synthesised in the liver, is converted to the active fibrinolytic enzyme plasmin. Whether thrombosis occurs or proceeds depends on the balance between the processes of thrombosis and fibrinolysis.
As fatty streaks progress they present more obstruction to normal flow, and endothelial cells may be lost. Fibrin and platelets may become deposited on the surface and protrude into the lumen, causing more turbulence, and a complicated atheromatous plaque develops. In addition to the risk of thrombosis on a complicated plaque there is also a risk from haemor- rhage within it, and when it occurs it causes the plaque to protrude even further into the lumen.
Virchows triad: Damage to the vessel wall: Venous thrombosis
Mechanical damage and vascular inflammation are the commonest causes of damage to venous walls, with subsequent thrombus formation. Inflammation of vessel walls, either arteries or veins, can cause thrombus formation, but the converse is also true. Thrombus initiates an inflammatory response, and in any given instance it can be difficult to say whether the process represents phlebothrombosis (thrombus due to inflammation) or thrombophlebitis (inflammation due to thrombosis). However, the commonest cause of venous thrombosis is alteration to blood flow.
Virchows triad: Alteration in blood flow
The normal laminar flow may change to a turbulent pattern. This may happen with:
- prolonged inactivity following surgery, trauma, or a myocardial infarction
- heart failure
- proximal occlusion of the venous drainage.
Alterations in blood flow are critical in the venous system since pressure is much lower and the normal rate of flow is much slower than in the arteries. As pressure is so much lower in the venous system and the vein walls are so much thinner than the walls of arteries of the same calibre, use is made of the pumping action of the surrounding muscle groups to aid return of blood to the heart.
Consequently any decrease in muscle activity deprives venous blood of this added action and relative stasis occurs. Thus venous thrombosis becomes more likely in the veins of immobile subjects. The elderly are particularly at risk since they often have a degree of venous impairment or relative cardiac failure. One of the commonest deficiencies of the elderly venous system is impairment of the function of venous valves, and thrombosis is often seen to begin at the site of valves where, even under normal circumstances, some degree of turbulence is to be expected.
Virchows triad: Alterations in the constituents of the blood
Alterations which may occur include:
• increased number and adhesiveness of platelets following surgery or injury;
• increased adhesiveness of young platelets produced at this time;
• fluid loss, which may increase viscosity; and
• thrombophilia – a variety of hypercoagulable states due to an abnormal balance of clotting factors and natural anticoagulants.
Factor V which plays a role in the conversion of prothrombin to thrombin is inhibited by Protein C, Protein S and antithrombin.
Congenital thrombophilia
• factor V Leiden – a variant of Factor V which is relatively resistant to Protein C (named after the town in Holland where the original research was done)
• protein C deficiency
• protein S deficiency
• antithrombin deficiency
• prothrombin 20210A – which results in increased
plasma levels of prothrombin.
Acquired thrombophilia:
Antiphospholipid (APL) syndrome
• Antiphospholipid (APL) syndrome, also known
as lupus ‘anticoagulant’ or Hughes’ syndrome,
an auto-antibody which may be associated with systemic lupus.
Platelet surface phospholipids play a part in the activation of the coagulation cascade. The production of these is affected in this condition.
Acquired thrombophilia:
myeloproliferative disorders
• myeloproliferative disorders: e.g. polycythaemia, thrombocythaemia and chronic myeloid leukaemia;
Acquired thrombophilia:
advanced malignancy
• advanced malignancy: increased coagulation due to substances produced by tumours as yet unidentified. The thrombosis tends to be particularly aggressive and cases of venous gangrene are almost always due to this cause;
Acquired thrombophilia: Hyperhomocysteinaemia
Hyperhomocysteinaemia: the formation of cysteine and methionine in the body, requires vitamin B12 and folic acid as cofactors. If there is any block in this process then homocysteine is formed. A raised homocysteine level is widely accepted as a risk factor for arterial disease and venous thrombosis. Adequate intake of folic acid and B vitamins reduce blood levels of homocysteine and studies are ongoing to see if this improves the outlook for vascular disease.
Indications for investigating for thrombophilia:
• positive family history of thrombosis;
• recurrent thrombosis;
• venous thrombosis before the age of 40–50;
• unprovoked thrombosis at any age;
• unusual sites such as cerebral, mesenteric, portal or hepatic veins;
• thrombosis during pregnancy, oral contraceptives
or hormone replacement therapy; and
• unexplained abnormal laboratory test such as
prolonged PTT.
Fate of a thrombus
Thrombi may: • undergo complete resolution • become organised as a scar • recanalise • embolise in whole or in part.
It is not clear what factors determine which of these fates a thrombus will suffer, although size may be a factor. Small thrombi are being formed and resolved constantly, and some degree of disturbance of blood flow is probably required to tip the scales and cause a thrombus to organise.
Certainly a larger thrombus will cause turbulence and/or inflammation and make it likely that further thrombosis will occur on its surface, causing the thrombus to lengthen, a process known as propagation.
Thrombus resolution
See diagram
Resolution means that the clot is completely dissolved by processes of thrombolysis. In the clinical setting this is achieved by the use of thrombolytic enzymes, e.g. plasminogen activator or urokinase, but these have to be delivered onto the clot more or less directly, otherwise they diffuse through the blood stream and may become so dilute that they are ineffectual.
Current therapies involve substances that act directly or indirectly on plasminogen activators. Compounds such as aspirin and heparin help prevent further thrombus formation but do not help in lysis of an established thrombus. If the thrombus is not completely removed then the residue undergoes organisation.
Thrombus organisation
Organisation is the process by which the thrombus is converted to a scar and eventually covered by endothelial cells. Intravascular scarring is essentially similar to those processes involved in the production of scars from thrombi in wound healing generally.
The main difference between intravascular granulation tissue and a thrombus is that with a thrombus the vascular phase of granulation tissue is prolonged and, if the thrombus does not resolve completely, the capillaries fuse together, resulting in one or several new vessels passing through the scar. This process is called recanalisation and in some cases may result in one or more functional vascular channels.
Thromboembolism
Thromboembolism is embolisation of a thrombus and should be distinguished from emboli of other materials since the clinical setting is different, as is the treatment. The effects of thromboemboli depend upon where the embolus settles, which in turn depends upon where the thrombus forms and what size the embolus is.
Emboli arising from thrombi in veins will all go to the lungs (unless there is an abnormal connection between right and left heart). They will generally not arrest early in the circulation since the veins increase in diameter with the direction of blood flow as they approach the lungs, and only then do they start to turn into progressively smaller vessels of the lung bed. Arterial emboli will arrest in the artery with the smallest calibre which they can enter, and this will always be more peripheral than their origin because arterial size decreases in the direction of blood flow.
Embolism
An embolus is an abnormal mass of undissolved material which passes in the blood stream from one part of the circulation to another, impacting in vessels too small to allow it to pass. The actual material which passes along the blood stream is termed an embolus. When it impacts and obstructs the flow of blood, this is known as an embolism. Thus when a thrombus in the leg breaks off, this is an embolus, and when it impacts in the pulmonary artery it is a pulmonary embolism. Emboli may consist of:
- thrombus
- gas (air and nitrogen)
- fat
- tumour
- amniotic fluid
- foreign body
- therapeutic emboli, e.g. gelfoam, muscle, steel coils.
Venous thromboembolism
The overwhelming majority of emboli arise from thrombus in the veins of the lower limbs. They then travel up through the inferior vena cava to the right side of the heart and finally impact in the pulmonary artery or one of its major branches, depending on the size of the embolus. The process of venous thrombosis and embolism is extremely common, and it has been estimated that approximately 30% of hospital inpatients have deep venous thrombosis (DVT) and in approximately 10% of postmortem examinations there is evidence of pulmonary embolism.
This is potentially such a common problem that most hospital in-patients should be on some form of prophylaxis against DVT. While mechanical methods such as elastic stockings and inflatable leggings used during operation are helpful, prophylactic subcutaneous heparin is probably the most reliable. Many hospitals now have a policy of giving heparin to all patients unless there is a specific contraindication.